Safety of Bevacizumab Treatment in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Full-Dose Anticoagulation (FDAC) Treated on Protocol BO17704
| Autor: | Skillings, J., LaFleur, F., Leighl, N., Bennouna, J., Kuo, H.-P., Szima, B., Gottfried, M., Kunitsyn, A., Trigo, J.M., Chang, G.-C., Cosaert, J., Manegold, C. |
|---|---|
| Zdroj: | In Clinical Lung Cancer July 2007 8(7):454-454 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect